Cargando…
Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19
This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672786/ https://www.ncbi.nlm.nih.gov/pubmed/35918988 http://dx.doi.org/10.4103/ijo.IJO_1021_22 |
_version_ | 1784832817063002112 |
---|---|
author | Eduarda Andrade e Andrade, Maria Rodrigues, Juliane Cardoso Junior, Elvio Ferreira de Lima, Mario Henrique Camargos |
author_facet | Eduarda Andrade e Andrade, Maria Rodrigues, Juliane Cardoso Junior, Elvio Ferreira de Lima, Mario Henrique Camargos |
author_sort | Eduarda Andrade e Andrade, Maria |
collection | PubMed |
description | This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and no other factor that could lead to the findings on his examinations. After treatment with high doses of topic, oral, and sub-conjunctival corticoids, the patient had a favorable therapeutic response. The signs of corneal transplant rejection must be oriented to the patients and the causing factors actively searched by ophthalmologists so that treatment is rapidly initiated and sequels are avoided. This report raises the question if these events are correlated and whether the patient should receive the second dose of the vaccine against SARS-CoV-2 or not. |
format | Online Article Text |
id | pubmed-9672786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-96727862022-11-19 Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 Eduarda Andrade e Andrade, Maria Rodrigues, Juliane Cardoso Junior, Elvio Ferreira de Lima, Mario Henrique Camargos Indian J Ophthalmol Case Reports This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and no other factor that could lead to the findings on his examinations. After treatment with high doses of topic, oral, and sub-conjunctival corticoids, the patient had a favorable therapeutic response. The signs of corneal transplant rejection must be oriented to the patients and the causing factors actively searched by ophthalmologists so that treatment is rapidly initiated and sequels are avoided. This report raises the question if these events are correlated and whether the patient should receive the second dose of the vaccine against SARS-CoV-2 or not. Wolters Kluwer - Medknow 2022-08 2022-07-29 /pmc/articles/PMC9672786/ /pubmed/35918988 http://dx.doi.org/10.4103/ijo.IJO_1021_22 Text en Copyright: © 2022 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Reports Eduarda Andrade e Andrade, Maria Rodrigues, Juliane Cardoso Junior, Elvio Ferreira de Lima, Mario Henrique Camargos Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
title | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
title_full | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
title_fullStr | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
title_full_unstemmed | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
title_short | Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19 |
title_sort | keratoplasty rejection after messenger rna vaccine (bnt162b2) for covid-19 |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672786/ https://www.ncbi.nlm.nih.gov/pubmed/35918988 http://dx.doi.org/10.4103/ijo.IJO_1021_22 |
work_keys_str_mv | AT eduardaandradeeandrademaria keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 AT rodriguesjulianecardoso keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 AT juniorelvioferreira keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 AT delimamariohenriquecamargos keratoplastyrejectionaftermessengerrnavaccinebnt162b2forcovid19 |